NCT06233500

Brief Summary

The goal of this prospective interventional study is to to compare the micro vascular and structural changes between surgery with and without ILM flap to repair macular hole. The main questions it aims to answer are:

  • What are the macular micro vascular and structural changes pre and post repair of idiopathic full thickness macular hole and what is the correlation between these changes and visual recovery.
  • Is there are any prognostic values of the micro vascular status of the macula could be assessed preoperatively.
  • What are the differences regarding these micro vascular and structural changes between repair with and without ILM flap. Participants will be:
  • Subjected to pars plana vitrectomy to repair macular hole.
  • Examined by optical coherence tomography angiography pre and post operative Researchers will compare: Group A: eyes treated without ILM flap Group B : eyes treated by ILM flap to see if there are differences regarding the micro vascular and structural changes in the macular area.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

January 22, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 31, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

2.2 years

First QC Date

January 22, 2024

Last Update Submit

January 22, 2024

Conditions

Keywords

macular holeILM peelingTemporal flapOCTAOptical Coherence Tomography Angiography

Outcome Measures

Primary Outcomes (2)

  • visual acuity

    Best corrected visual acuity measurement using Snellen chart with conversion to log. MAR notation for statistical analysis

    It will be measured preoperative and at 1 and 6 months post-operative

  • Fovea avascular zone FAZ

    Optical coherence tomography angiography used to measure FAZ area in mm2 (mm square)

    It will be measured preoperative and at 1 and 6 months post-operative

Secondary Outcomes (1)

  • central retinal thickness

    It will be measured preoperative and at 1 and 6 months post-operative

Study Arms (2)

Group A: eyes will be treated without ILM flap

ACTIVE COMPARATOR

Group A: Only wide ILM peeling up to the arcades well be done

Procedure: pars plana vitrectomy

Group B : eyes will be treated by ILM flap

ACTIVE COMPARATOR

Group B: ILM peeling with flap well be done

Procedure: pars plana vitrectomy

Interventions

All eyes in this study will be subjected to pars plana vitrectomy procedure with these main steps: * 23 G trocar system will be used * Posterior vitreous detachment will be induced with the aid of triamcinolone acetate injection, and core vitrectomy will be done * Brilliant blue stain will be injected, and ILM forceps will be used for ILM peeling Patients will be divided then into two groups: Group A: Only wide ILM peeling up to the arcades well be done Group B: ILM peeling with flap well be done * Shaving of the vitreous base, and then fluid air exchange * SF 6 gas tamponade will be used

Also known as: PPV with ILM peeling
Group A: eyes will be treated without ILM flapGroup B : eyes will be treated by ILM flap

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Idiopathic full thickness Macular hole without retinal detachment

You may not qualify if:

  • Previous pars plana vitrectomy
  • High myopia with axial length ≥ 26 mm.
  • Uncertain symptom duration or ≥ 6 month .
  • History of same eye trauma
  • Poor image quality.
  • Patients with diabetic retinopathy or other retinal diseases, e.g. ischemic, inflammatory.
  • Any patient with significant cataract which needs combined phaco-vitrectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

research institute of ophthalmology, Egypt

Giza, 12511, Egypt

RECRUITING

Related Publications (11)

  • Demirel S, Degirmenci MFK, Bilici S, Yanik O, Batioglu F, Ozmert E, Alp N. The Recovery of Microvascular Status Evaluated by Optical Coherence Tomography Angiography in Patients after Successful Macular Hole Surgery. Ophthalmic Res. 2018;59(1):53-57. doi: 10.1159/000484092. Epub 2017 Nov 29.

    PMID: 29183023BACKGROUND
  • Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol. 1991 May;109(5):654-9. doi: 10.1001/archopht.1991.01080050068031.

    PMID: 2025167BACKGROUND
  • Lai MM, Williams GA. Anatomical and visual outcomes of idiopathic macular hole surgery with internal limiting membrane removal using low-concentration indocyanine green. Retina. 2007 Apr-May;27(4):477-82. doi: 10.1097/01.iae.0000247166.11120.21.

    PMID: 17420702BACKGROUND
  • Casini G, Mura M, Figus M, Loiudice P, Peiretti E, De Cilla S, Fuentes T, Nasini F. INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE FOR MACULAR HOLE SURGERY WITHOUT EXTRA MANIPULATION OF THE FLAP. Retina. 2017 Nov;37(11):2138-2144. doi: 10.1097/IAE.0000000000001470.

    PMID: 28129215BACKGROUND
  • Yun C, Ahn J, Kim M, Kim JT, Hwang SY, Kim SW, Oh J. Characteristics of retinal vessels in surgically closed macular hole: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1923-1934. doi: 10.1007/s00417-017-3742-6. Epub 2017 Jul 25.

    PMID: 28744658BACKGROUND
  • Woon WH, Greig D, Savage MD, Wilson MC, Grant CA, Mokete B, Bishop F. Movement of the inner retina complex during the development of primary full-thickness macular holes: implications for hypotheses of pathogenesis. Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2103-9. doi: 10.1007/s00417-015-2951-0. Epub 2015 Feb 13.

    PMID: 25673252BACKGROUND
  • Itoh Y, Inoue M, Rii T, Ando Y, Hirakata A. Asymmetrical recovery of cone outer segment tips line and foveal displacement after successful macular hole surgery. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):3003-11. doi: 10.1167/iovs.14-13973.

    PMID: 24736052BACKGROUND
  • Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015 Jan;133(1):45-50. doi: 10.1001/jamaophthalmol.2014.3616.

    PMID: 25317632BACKGROUND
  • Lupidi M, Coscas F, Cagini C, Fiore T, Spaccini E, Fruttini D, Coscas G. Automated Quantitative Analysis of Retinal Microvasculature in Normal Eyes on Optical Coherence Tomography Angiography. Am J Ophthalmol. 2016 Sep;169:9-23. doi: 10.1016/j.ajo.2016.06.008. Epub 2016 Jun 11.

    PMID: 27296485BACKGROUND
  • Samara WA, Say EA, Khoo CT, Higgins TP, Magrath G, Ferenczy S, Shields CL. CORRELATION OF FOVEAL AVASCULAR ZONE SIZE WITH FOVEAL MORPHOLOGY IN NORMAL EYES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2015 Nov;35(11):2188-95. doi: 10.1097/IAE.0000000000000847.

    PMID: 26469536BACKGROUND
  • Kim YJ, Jo J, Lee JY, Yoon YH, Kim JG. Macular capillary plexuses after macular hole surgery: an optical coherence tomography angiography study. Br J Ophthalmol. 2018 Jul;102(7):966-970. doi: 10.1136/bjophthalmol-2017-311132. Epub 2017 Oct 5.

    PMID: 28982954BACKGROUND

MeSH Terms

Conditions

Retinal Perforations

Interventions

Predictive Value of Tests

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Sensitivity and SpecificityEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Islam Mohalhal, MD

    Research Institute of Ophthalmology, Egypt

    STUDY DIRECTOR

Central Study Contacts

Mohamed Husssein

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will include 28 eyes with idiopathic full thickness macular hole; All eyes in this study will be subjected to pars plana vitrectomy procedure, they will be divided into two groups: Group A: 16 eyes will be treated with only wide internal limiting membrane (ILM) peeling up to the arcades without ILM flap Group B : 16 eyes will be treated by ILM peeling with ILM flap.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

January 22, 2024

First Posted

January 31, 2024

Study Start

December 1, 2021

Primary Completion

March 1, 2024

Study Completion

March 15, 2024

Last Updated

January 31, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
data will become available before the end of 2024 and will be available for 1 year
Access Criteria
it will be shared via E-mail

Locations